Lobbying Relationship

Client

ORGANON & CO.

More records

Lobbying firm

ORGANON & CO.

More records

  • HR 1352--Increasing Access to Biosimilars Act HR 5376 (117th Congress)--Inflation Reduction Act of 2022--Drug pricing/biosimilars Women's health Biosimilars H.R.2882 - Further Consolidated Appropriations Act, 2024

Duration: to

General Issues: Medicare/Medicaid, Health Issues, Family Issues/Abortion/Adoption

Spending: about $4,040,000 (But it's complicated. Here's why.)

Agencies lobbied since 2021: U.S. Senate, House of Representatives, Natl Economic Council (NEC), White House Office, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

Affiliated organizations: Organon LLC

Bills mentioned

S.1427: Increasing Access to Biosimilars Act of 2021

Sponsor: John Cornyn (R-Texas)

H.R.2869: Increasing Access to Biosimilars Act of 2021

Sponsor: Tony Cárdenas (D-Calif.)

H.R.2815: BIOSIM Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.2855: Star Rating for Biosimilars Act

Sponsor: Paul Tonko (D-N.Y.)

H.R.5376: Inflation Reduction Act of 2022

Sponsor: John Yarmuth (D-Ky.)

S.CON.RES.14: A concurrent resolution setting forth the congressional budget for the...

Sponsor: Bernard Sanders (ID-Vt.)

H.R.1352: Increasing Access to Biosimilars Act of 2023

Sponsor: Richard Hudson (R-N.C.)

H.R.5376: Share the Savings with Seniors Act

Sponsor: Mariannette Miller-Meeks (R-Iowa)

H.R.2882: Further Consolidated Appropriations Act, 2024

Sponsor: Juan Ciscomani (R-Ariz.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Rebecca Mandell Legislative Assistant, Sen. Frank Lautenberg
Nicholas Schemmel Rep. Earl L. Buddy Carter-Legislative Director, Senior Policy Advisor, Legislative Assistant; Rep. Jack Kingston--Intern

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page